DOI: 10.1111/apt.17800 ISSN: 0269-2813

Letter: interpretation of the BESST trial in the context of baseline antidepressant and neuromodulator use

Brent Hiramoto, Walter W. Chan
  • Pharmacology (medical)
  • Gastroenterology
  • Hepatology
Show PDF Cite

LINKED CONTENT

This article is linked to Parkman et al papers. To view these articles, visit https://doi.org/10.1111/apt.17479 and https://doi.org/10.1111/apt.17838

More from our Archive